|
Mucositis/ Stomatitis/ Oesophagitis is an inflammatory reaction of the mucous lining of, the upper gastrointestinal tract from mouth to stomach (mouth, lips, throat), and surrounding soft tissues. Characterised by ulcers and /or erythema, that can cause soreness and significant pain that will reduce dietry and fluid intake. MASCC - Mucositis affects the inner lining of the oral and gastrointestinal tract. Oral mucositis often leads to difficulty eating and swallowing; gastrointestinal mucositis is associated with nausea, vomiting, diarrhea, bloating, intestinal cramping, and anal pain. For patients who are immunosuppressed, oral mucositis is associated with greater risk for bacteremia, which has possible systemic implications. Patients experiencing mucositis often require enteral or parenteral nutrition, consume more opioids, and experience more interruptions to cancer therapy than patients who do not experience mucositis. |
Are you a health professional looking for immediate guidance?UKONS Acute Oncology Initial Management may help |
National and International guidelines: |
|
MANAGEMENT OF ORAL AND GASTROINTESTINAL MUCOSAL INJURY: ESMO CLINICAL PRACTICE GUIDELINES |
|
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy: First published: 28 July 2020 |
We are eager to develop the content of this page and would be pleased to accept contributions and suggestions, please contact us if you are able to help
Please note that you should always assume that the authors and owners of any of these documents make no representations or guarantees as to the accuracy, completeness or adequacy of any of the content and make no warranties express implied or otherwise and cannot be held responsible for any liability, loss or damage whatsoever caused by the use of the content. You should always act within the limits of your competence and seek senior advice or support where appropriate.